FLT3 and acute myeloid leukemia: In the 2017 European LeukemiaNet (ELN) assessment of molecular cytogenetic risk groups in AML, FLT3-ITD was implicated in risk stratification depending on its allelic ratio and the NPM1 mutation status [72,73,74].